RJFSA
CLVS

Raymond James Financial Services Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Raymond James Financial Services Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-21,159
Closed -$962K – 2911
2018
Q2 		$962K Buy
21,159
+814
+4% +$39.6K ﹤0.01% 1447
2018
Q1 		$1.07M Sell
20,345
-1,220
-6% -$71.2K 0.01% 1261
2017
Q4 		$1.47M Buy
21,565
+9,100
+73% +$636K 0.01% 1059
2017
Q3 		$1.03M Buy
12,465
+5,440
+77% +$431K 0.01% 1291
2017
Q2 		$658K Buy
+7,025
New +$430K ﹤0.01% 1530

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Raymond James Financial Services Advisors's CLVS Position: Q3 2018 in Review

Raymond James Financial Services Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q3 2018, closing a stake of 21,159 shares — an estimated $962K sold.

Raymond James Financial Services Advisors first reported a position in CLVS in Q2 2017 and held it in 5 quarters. The position peaked at $1.47M in Q4 2017. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2018.

  • Raymond James Financial Services Advisors reported no remaining Clovis Oncology, Inc. position as of Q3 2018 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 21,159 Clovis Oncology, Inc. shares in Q3 2018, an estimated $962K.
  • Raymond James Financial Services Advisors first reported a position in Clovis Oncology, Inc. in Q2 2017 and held it in 5 quarters.
  • Raymond James Financial Services Advisors's Clovis Oncology, Inc. position peaked at $1.47M in Q4 2017.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2018.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.